Human α-Galactosidase A Mutants: Priceless Tools to Develop Novel Therapies for Fabry Disease is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
Grant: Explore 2
Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
Grant: PegLyso
Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
Grant: ADVERT
Agència de Gestió d'Ajuts Universitaris i de Recerca
Grant: 2017 SGR-229
NIGMS NIH HHS
Grant: R01 GM129325
National Institutes of Health
Grant: 5R01GM129325-08
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling
European Commission
Grant: 720942
Smart multifunctional GLA-nanoformulation for Fabry disease
FWCI
1.48
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals